Stock listing

Stuttgart:36X Ascentage Pharma Group International Aktie

German listing (Stuttgart) of Ascentage Pharma Group International · home listing HKEX:6855

Follow Ascentage Pharma Group International into a list and get an email when it puts out news.

Home listing price · HKEX:6855

$29.74 HKD +1.72 (+6.1%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:6855

Past year -59.0% · daily closes, Oct 16, 2025 – Oct 16, 2026, adjusted for splits
Day range
$28.80 – $30.28 HKDOct 16, 2026
Volume
3.12M sharesOct 16, 2026
52-week range
$27.12 – $73.20 HKDLowest and highest trades, Oct 17, 2025 – Oct 16, 2026
Ascentage Pharma Group International logo
Ticker
Stuttgart:36X
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stuttgart
Currency
EUR

What changed lately

Calls

Replays

  • Ascentage Pharma Group International (HKEX:6855) Q2 2026 Earnings Call

    Thu, Aug 20, 2026 · 9:00 AM ET

    Watch Transcript

  • Ascentage Pharma Group International (HKEX:6855) Q4 2025 Earnings Call

    Thu, Mar 26, 2026 · 10:00 AM ET

    Watch Transcript

  • Ascentage Pharma Group International (HKEX:6855) Q2 2025 Earnings Call

    Thu, Aug 21, 2025 · 8:00 AM ET

    Watch Transcript

Latest news

Voluntary announcement - purchase of shares by the trustee for the purpose of the 2022 RSU scheme

Oct 15, 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

Oct 7, 2026

Voluntary announcement - acquisition of shares by the chairman and executive director

Sep 28, 2026

Interim report 2026

Sep 16, 2026

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

Aug 19, 2026

CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Aug 5, 2026

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Aug 2, 2026

Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026

Jul 26, 2026

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

Jun 14, 2026

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026

May 31, 2026

All Ascentage Pharma Group International news

Decks

Ascentage Pharma Group International on 6ix

Sector
Health care
Industry
Biotechnology
News releases
40 in the last 12 months · 58 in all · newest Oct 15, 2026 · oldest 2025
Calls
3 calls with a replay · 3 with a transcript · latest Aug 20, 2026
Decks
13 decks · latest Aug 20, 2026

Where Ascentage Pharma Group International is listed

ListingExchangeCountryCurrency
HKEX:6855 亞盛醫藥 · Home listingHKEXHong KongHKD
NASDAQ:AAPGNASDAQUnited StatesUSD
OTC:ASPHFOTCUnited StatesUSD
LS Exchange:A2PUCQLS ExchangeGermanyEUR
Lang & Schwarz:A2PUCQLang & SchwarzGermanyEUR
BOATS:AAPGBOATSUnited StatesUSD
Dusseldorf:36X0DusseldorfGermanyEUR
Frankfurt:36XFrankfurtGermanyEUR
Frankfurt:36X0FrankfurtGermanyEUR
Lang & Schwarz:A40ZYRLang & SchwarzGermanyEUR
LS Exchange:A40ZYRLS ExchangeGermanyEUR
Stuttgart:36X · This pageStuttgartGermanyEUR
Stuttgart:36X0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Ascentage Pharma Group International.